Companies Dominating the Air Insulated Switchgear Market
- C and S Electric Ltd.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CG Power and Industrial Solutions Ltd.
- Eaton Corp. Plc
- ELATEC POWER DISTRIBUTION GmbH
- EPE Switchgear M Sdn. Bhd.
- General Electric Co.
- Larsen and Toubro Ltd.
- Lucy Group Ltd.
- Schneider Electric SE
- Siemens AG
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of air insulated switchgear is assessed at USD 70.21 billion.
The global air insulated switchgear market is expected to expand from USD 67.84 billion in 2024 to USD 127.92 billion by 2037, witnessing a CAGR of over 5% throughout the forecast period, between 2025 and 2037.
Asia Pacific industry is poised to hold largest revenue share of 38% by 2037, impelled by increasing inclination toward renewable energies in the region.
The major players in the market include Bayer AG, Mayne Pharma Group Limited, PULMATRiX Inc., Endo International Plc, Johnson & Johnson Services Inc., GlaxoSmithKline Plc, Pfizer Inc., Abbott, Takeda Pharmaceutical Company Limited, Novartis AG, Shionogi & Co., Ltd., Asahi Kasei Pharma Corporation, F2G Ltd., Regeneron Pharmaceutical Inc.
